Professor Stephen Johnston retweeted
Exploring the treatment gap and outcome risks in patients with node+, high-risk, HR+, HER2- early BC: analyses of RW data in @ESMO_Open. Only 40% of eligible pts received adj abemaciclib. Eligible not treated: similar TNBC recurrence/mortality risk. esmoopen.com/article/S2059-7…
Professor Stephen Johnston retweeted
This is HUGE. 20 years after the approval of the latest adjuvant ET, a novel SERD may join the adjuvant arena. In the lidERA phase 3 trial, giredestrant significantly improved iDFS vs SoC ET in patients with stage I-III ER+ BC, with a positive OS trend. roche.com/media/releases/med…
Professor Stephen Johnston retweeted
Adding abemaciclib to ET improves OS in pts with HR-positive, HER2-negative, node-positive, high-risk early breast cancer, according to results from the monarchE trial presented at #ESMO25 by @professorSteph7 of @royalmarsdenNHS. #bcsm #ESMO2025
cancertherapyadvisor.com/rep…
Professor Stephen Johnston retweeted
@ProfJohnCrown shared 5-year results from the NATALEE trial 🧬
Adjuvant ribociclib + aromatase inhibitors showed lasting benefit in HR+/HER2- early BC
✅ ~28% lower risk of recurrence or death
✅ Benefit seen even in node-neg (4/4)
Professor Stephen Johnston retweeted
@professorsteph7 shared a 1st look at overall survival in the monarchE trial:
Abemaciclib + hormone therapy improved OS in node+ HR+/HER2- early BC
✅Risk of death reduced by15.8%
✅Metastases reduced (14% vs 20%)
✅First CDK4/6 inhibitor to show OS gain in adjuvant setting (3/4)
Professor Stephen Johnston retweeted
Don’t miss the opportunity to learn about the foundations, evidence, & practicalities of use of oral #SERDs in ER+ #MBC in this virtual #MedEd Part 1 workshop hosted by @jhaveri_komal and expert @professorSteph7 on 8/13 at 12:00 PM EDT! Produced with @MBCaware bit.ly/SERD25-T #BCSM
Professor Stephen Johnston retweeted
Updated data from #monarchE trial presented at #SABCS22: greater benefit with longer follow-up by adding #abemaciclib to adjuvant endocrine therapy in high-risk #BreastCancer patients…too early for assessing overall survival @SABCSSanAntonio @OncoAlert #bcsm
Lots of new data over last year to help us with decision making in HR+ EBC - always great to debate these with colleagues attending APBCS
Stephen Johnston @professorSteph7 walks us through practice-changing trials in the HR+ Early stage breast cancer setting at the APBCS 2022!
#apbcs2022 #breastcancer
@Shaheenah1 @RebeccaDSing
5
Professor Stephen Johnston retweeted
#monarchE: Practice changing benefit confirmed in #EBC. Don't miss Stephen R D Johnston, MD from the Royal Marsden and Nadia Harbeck, MD highlighting the facts on #high5oncologyTV. Tune in on 👉https://xitter.gq/t.co/kBQzJ2i5G9
Professor Stephen Johnston retweeted
The @myESMO Virtual Plenary of tomorrow is highly expected: does abema improve DFS in pts with M0 HR+ BC with longer F-up ? If benefit ⤴️ over time; how to explain the diff w trials testing palbo ? Concomitant publi in @Annals_Oncology esmo.org/meetings/october-vi…
Professor Stephen Johnston retweeted
FDA Approves Adjuvant Abemaciclib Plus Endocrine Therapy for Select HR+ Early Breast Cancer onclive.com/view/fda-approve… via @onclive @professorSteph7 – at Hounslow, London
Professor Stephen Johnston retweeted
Two must-read @ASCO Guideline Updates on the treatment of HER2-negative MBC just out on JCO - featuring a stellar panel of experts
Strong endorsement for ET first in HR+ pts, single agent chemo over polychemo & wide guidance on novel biologic options
ascopubs.org/doi/abs/10.1200…
Professor Stephen Johnston retweeted
We're so sorry to hear this sad news & are thinking of Helen's loved ones at this very difficult time. Helen & Damian’s support with #FeedTheNHS, a wonderful initiative established in the pandemic, supported @royalmarsdenNHS & thousands of NHS staff with free meals. Thank you🙏
A remarkable film
A heartbreaking watch- thinking of @kategarraway & the family. This documentary was filled with so much hope. Well done @anna_johnston & @OiWilcox for making an incredibly poignant film that summed up what the last year has been like for so many #FindingDerek
Professor Stephen Johnston retweeted
Please tune in tonight ITV 9pm! 💛
Tonight at 9 on ITV - the raw & intimate story of Kate Garraway’s husband’s battle with Covid-19. Directed & filmed by the brilliant @OiWilcox & AP @anna_johnston #FindingDerek
Great #RMBreastCancerMeeting yesterday giving update on recent research & treatment for breast cancer in the new Covid world. Thanks to RM colleagues & @trmeducation who helped organise our annual Hot Topics virtual meeting, and @RCPLondon for hosting.
Thank you so much to everyone who took part in today’s event #RMBreastCancerMeeting
Special thanks to all of our exceptional speakers, sponsors, and our amazing audience.Looking forward to see you soon again! ow.ly/GPIm50BHWc2
@RCPLondon @professorSteph7 @FionaMacNeill1
Professor Stephen Johnston retweeted
We are proud to announce Phase 3 monarchE clinical trial data at #ESMO20 for a particular type of high risk early #breastcancer. Learn more: e.lilly/2RIBtRn
Many thanks to all patients, investigators & trial sponsor @LillyPad involved in the monarchE adjuvant breast cancer trial presented @ESMO. These are exciting results for those with high risk hormone receptor positive early #breastcancer. An impressive digital meeting #ESMO2020

































